- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Last Hurrah From National Academies Stem Cell Committee
26 May 2010 4:15 pm
Even though the National Institutes of Health (NIH) issued stem cell guidelines last year, there's still a need for guidelines for research that remains off-limits for U.S. government-funded labs. That's one message from a brief final report released today by the National Academies' National Research Council and Institute of Medicine committee on human embryonic stem (hES) cells.
In its third update to a 2005 report, the committee says that NIH's guidance should prevail over the Academies' whenever there's overlap. But guidelines such as the Academies' are still needed for research that can't be done with federal grants, says the six-page report (not counting appendices). That includes the derivation of new lines, work involving animal-human cell chimeras, and studies with lines made from embryos that were created for research purposes.
The committee decided to disband because any big controversies in the future will likely center on the uses of stem cells rather than their derivation. But the National Academies may want to hold forums with stakeholders on stem cell topics, the report suggests.